STAT
JUNE 11, 2025
Europe’s comparatively cautious approach to food additives is the envy of health secretary Robert F. Kennedy Jr. and the Make America Healthy Again movement. A Texas bill now before Gov. Greg Abbott aims to help close the gap by slapping warning labels on foods that contain any of 44 additives and dyes. Abbott has not said whether he intends to sign Senate Bill 25 into law.
PharmaVoice
JUNE 10, 2025
Ronny Gal, chief strategy and growth officer at Novartis, is guiding the company into a new era shaped by science-minded M&A and a slimmed-down pivot.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 6, 2025
A monthly treatment from Otsuka reduced by more than half the levels of a toxic protein in the urine of patients with an autoimmune kidney disease. The results presented Friday achieved the interim goal of a Phase 3 study and were numerically superior to study results posted Monday by competitor Vera Therapeutics. The Otsuka drug, called sibeprenlimab, lowered proteinuria levels by 50.2% after nine months compared to an increase of 2.1% in patients given a placebo.
PharmaVoice
JUNE 9, 2025
Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Express Pharma
JUNE 8, 2025
According to the GlobalData report, the global pharma industry reported 76 mergers and acquisitions (M&A) deals in May 2025, amounting to a total disclosed value of $6.96 billion. This figure marks a decline compared to the previous 12-month average from May 2024 to April 2025, which recorded 95 deals worth $12.4 billion. According to industry data, three major transactions contributed 59 per cent of the total deal value in May.
Med Ed 101
JUNE 8, 2025
Angiotensin II receptor blockers (ARBs) are widely used in managing hypertension, heart failure, chronic kidney disease (CKD), and diabetic nephropathy. While these agents share a common mechanism—blocking the angiotensin II type 1 (AT₁) receptor—not all ARBs are created equal. As healthcare professionals, understanding the nuanced differences can guide therapy optimization, especially in patients with comorbidities […] The post Losartan Differences – A Deep Dive on ARBs appeared fir
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
PharmaVoice
JUNE 6, 2025
Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve
NY Times
JUNE 10, 2025
Pharmacy benefit managers have used anti-competitive practices to dominate the prescription drug market.
pharmaphorum
JUNE 10, 2025
MSD could soon enter the US market for drugs used to protect infants from RSV infections, setting up a rivalry with AstraZeneca/Sanofi's Beyfortus
The Pharmacist
JUNE 9, 2025
Access to ear and hearing healthcare is becoming increasingly challenging. According to RNID, four in ten patients wait longer than six weeks on average for an audiology assessment. In addition, the postcode lottery of wax removal services in the UK is leading to dangerous self-management. Hearing loss is far more than just a minor inconvenience […] The post Pharmacists are well placed to take the lead on ear health appeared first on The Pharmacist.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
JUNE 9, 2025
Health secretary Robert F. Kennedy Jr. has taken the extraordinary step of firing the expert panel that advises the Centers for Disease Control and Prevention, saying the action is needed to restore faith in vaccines. “A clean sweep is needed to re-establish public confidence in vaccine science,” Kennedy said in an op-ed published Monday afternoon in the Wall Street Journal.
Express Pharma
JUNE 6, 2025
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterised by scarring of lung tissue, leading to impaired lung function and respiratory symptoms. The emerging therapies aim to address unmet needs in IPF management by targeting specific fibrotic pathways. Therapies such as LYT-100 by PureTech, currently in Phase IIb clinical trials, show promise in potentially offering improved efficacy and safety profiles, as it is a deuterated form of pirfenidone, which allows it
Pharmafile
JUNE 10, 2025
Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat patients with primary immunoglobulin A nephropathy (IgAN), a chronic kidney disease. The Japanese biopharma is now looking ahead to a prospective phase 3 trial of mezagitamab. The data was presented at the European Renal Association Congress on 6 June 2025 […] The post Takeda presents positive results from trial of chronic kidney disease treatment appeared first on Pharmafi
NY Times
JUNE 11, 2025
Skip to content Skip to site index Today’s Paper Opinion | It’s Code Red for Vaccines [link] Share full article 205 205 Advertisement SKIP ADVERTISEMENT You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load. Opinion Supported by SKIP ADVERTISEMENT Guest Essay It’s Code Red for Vaccines June 11, 2025, 5:03 a.m.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
JUNE 8, 2025
Four members of the 19-person expert panel that advises the Centers for Disease Control and Prevention on vaccination policy have been informed that their status as special government employees has been terminated — a development that throws into question their ability to continue to work on the body, STAT has learned. The Advisory Committee on Immunization Practices has been in the crosshairs of health secretary Robert F.
Drug Patent Watch
JUNE 9, 2025
"Navigating the Maze of Regulations: How Pharmaceutical Companies Can Safeguard Their Drug Portfolios As the pharmaceutical industry continues to evolve, regulatory environments are becoming increasingly complex. With new laws and guidelines emerging regularly, companies must stay agile to avoid costly delays and maintain market competitiveness.
Express Pharma
JUNE 11, 2025
Scientific discovery has always relied on good, clean data. Bad data leads to ir- reproducible outcomes, prob- lematic solutions, and, ultimately, the need to revisit and acquire better data. Now that AI-driven predictive models are becoming more commonplace in early drug discovery workflows, the importance of data that is ac- curate and consistent across en- tire research workflows has never been greater.
Pharma Times
JUNE 10, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Tagomics secures £860k grant for colorectal cancer test by John Pinching | 10th Jun 2025 | News Biotech firm to collaborate with NHS on early detection study Tagomics has been awarded £860k in funding from Innovate UK’s Biomedical Catalyst programme to develop a novel diagnostic test for colorectal cance
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
JUNE 12, 2025
A reputation is tough to build and easy to bruise. For drugmakers stuck in reputational limbo, embracing a clear direction and forward-thinking strategy can foster a rosier image.
STAT
JUNE 10, 2025
We recently went viral. Well, not exactly us — but people like us. We are participants in the Yale LISTEN Study , a patient-centered study to better understand long Covid and the adverse effects some patients have experienced post Covid-vaccination. We are members of the post-vaccination cohort, a group that includes more than 250 patients.
European Pharmaceutical Review
JUNE 12, 2025
Researchers have developed a once-weekly oral capsule with an innovative delayed drug release mechanism. This development could help certain patients, such as those with schizophrenia , to take their medicines more consistently. As the drug device can be delivered orally , the new pill “represents an important option that can assist with adherence for the many patients who would prefer oral medications versus injectable formulations,” explained Leslie Citrome, a Clinical Professor of psychiatry
Express Pharma
JUNE 6, 2025
Dr Saloni Wagh, Managing Director, and Shivani Wagh, Joint Managing Director of Supriya Lifescience, have been named in the 2025 Candere Hurun India Women Leaders List. The list, compiled by Candere and Hurun India, features 95 women leaders who have demonstrated business leadership and contributed to the Indian economy. The 2025 edition of the list follows the theme “Celebrating Women Creating Opportunities.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
BioPharma Dive
JUNE 10, 2025
The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned with Robert F. Kennedy Jr.’s skeptical views, analysts warned.
The Pharmacist
JUNE 6, 2025
A flu vaccination walk-in finder that will help patients easily look up where they can walk into a community pharmacy to have a vaccine is to launch later this year, NHS England has announced. In its new urgent and emergency care plan 2025/26, NHS England has unveiled plans for a ‘flu walk-in finder’ in a […] The post Pharmacy flu vaccination ‘walk-in finder’ to launch later this year appeared first on The Pharmacist.
STAT
JUNE 9, 2025
The National Institutes of Health has, for now, walked back a policy requiring universities and other research institutes to certify that they do not have unlawful diversity, equity, and inclusion programs or boycotts of Israel in order to receive research dollars. The rule, which was initially posted in April , was seen as the next stage of using research funds as leverage against private universities and efforts to increase diversity in the sciences.
Pharmafile
JUNE 10, 2025
June 10, 2025 – Lubrizol announces that an Apisolex™ polymer excipient-enabled drugformulation is in Phase 1 clinical trials. Introduced to the market in 2022, Apisolex polymer excipient is a polyamino acid-basedpolymer that enhances the solubility of BCS Class II and IV active pharmaceuticalingredients (API). Apisolex polymer excipient is manufactured following GoodManufacturing Practices (GMP) guidelines and […] The post Lubrizol announces an important milestone for its novelpatent
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Express Pharma
JUNE 9, 2025
The Confederation of Indian Industry (CII), Telangana, has announced the “Pillars of Protection – Forging a Safer Future for Pharma and Chemical Manufacturing” conference, which is scheduled to take place on 25th June 2025 in Hyderabad. The event is positioned as a strategic forum for stakeholders across the pharmaceutical and chemical sectors, including industry leaders, regulators, safety experts, and operational heads.
BioPharma Dive
JUNE 11, 2025
The company is paying $350 million upfront, and potentially over $1.3 billion overall, for a radiopharmaceutical for prostate cancer that works differently than Novartis’ Pluvicto.
PharmaTech
JUNE 10, 2025
News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer
STAT
JUNE 9, 2025
The Make America Healthy Again movement has a lot of the food industry on edge. Health secretary Robert F. Kennedy Jr. and his allies have made concerns about the health effects of ultra-processed foods a government priority , putting titans like PepsiCo, Kraft Heinz, and Nestlé on the defensive. But for a smaller contingent of food companies with products that align with MAHA’s vision of what a healthy diet looks like — from organic produce to emulsifier-free chocolates
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
298 
Let's personalize your content